Inhibition of inter-alpha trypsin inhibitor for the treatment of airway disease

Details for Australian Patent Application No. 2009325088 (hide)

Owner Duke University Prothera Biologics Inc. The United States of America, as represented by the Secretary, Department of Health and Human Services

Inventors Garantziotis, Stavros; Lim, Yow-Pin; Hollingsworth, John W.; Foster, W. Michael

Agent Fisher Adams Kelly

Pub. Number AU-A-2009325088

PCT Pub. Number WO2010/068308

Priority 61/121,407 10.12.08 US

Filing date 1 April 2009

Wipo publication date 17 June 2010

International Classifications

A61K 31/726 (2006.01) - Glycosaminoglycans, i.e. mucopolysaccharides

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/727 (2006.01)

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

2 June 2011 PCT application entered the National Phase

  PCT publication WO2010/068308 Priority application(s): WO2010/068308

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009325091-5-lipoxygenase-activating protein inhibitor

2009325082-Method and apparatus for discovery of relay nodes